2 new malaria treatments show promise as drug resistance grows

Researchers on Wednesday reported two promising new approaches to counteract malaria’s growing resistance to medication — one involving a new class of drugs.Switzerland-based Novartis released results of what it called a next-generation treatment. A study of its experimental drug in 12 African countries found it works well against the mosquito-borne parasite that causes malaria and seems to block spread.The drug, called GanLum, is not yet licensed and more than a year away from being available.It's needed, said Dr. David Sullivan, a malaria expert at Johns Hopkins University.The parasite …READ FULL ARTICLE